Anti covid pill, Burioni: “If approved, we will have home care”

If Merck’s ‘anti-covid pill’ is approved, “we will finally have home care.” Professor Roberto Burioni comments on Twitter the news regarding the antiviral drug molnupiravir shows to reduce the risk of hospitalization and death by about 50%. “If molnupiravir (Merck’s anti-covid drug) is approved we will finally have home care. Which came – coincidentally – from serious researchers and not from the nourished and vociferous troops of scoundrels who self-certify misunderstood genes”, writes the virologist. on the “fantastic news”. “Merck just announced that its new drug, given early to patients at risk with covid-19, halves the risk of hospitalization and death. To be precise, none of the patients who took the (oral) drug died.” summarizes the virologist, highlighting that “this drug could also be active against future coronaviruses that have the bad idea of ​​trying to jump from animals to humans. We cross our fingers and await the scientific work for a final judgment. I add that the treatment with this the drug costs 700 dollars, while the vaccination costs a few tens of dollars. So please don’t act in the interests of big pharma and get vaccinated “. So, the dig at no vax: “If they approve M”, writes Burioni identifying the drug with the initial, “one of the advantages will be that novax will not be able to become nomolnupiravir because it is too difficult a word for them both to write and to pronounce. “.